Publications by authors named "Myrianthi Bei"
Article Synopsis
- Human beta-defensin-1 (hBD-1) levels were analyzed in patients with decompensated cirrhosis, particularly focusing on those with acute-on-chronic liver failure (ACLF), to assess their relationship with mortality.
- The study included 125 patients split into three groups: those with ACLF, those with acute decompensation without ACLF, and those with stable decompensated cirrhosis, alongside healthy controls for comparison.
- Results showed that higher levels of hBD-1 were linked to worse outcomes in ACLF patients, with hBD-1 emerging as a strong independent predictor of 60-day mortality, while other markers like C-reactive protein were not effective.
